July 9th 2020. The RECOPHARMA Project yesterday presented examples of learning from good practice at the recently held policy co-creation workshop organised by the EU Horizon 2020 funded initiative XPRESS. The XPRESS project itself focuses on supporting the collaboration between local governments and Small and Medium Enterprises (SMEs) via Green Public Procurement (GPP) for the development and adoption of renewables across Europe.
The co-creation workshop, held on July 8th, was organised to facilitate the dialogue between private and public stakeholders with regard to GPPs and the opportunities they can generate as well as the challenges both local authorities and SMEs have to face. A key aim of the workshop, and one supported by RECOPHARMA’s participation, was to identify good practice examples, considering both barriers (including EU procurement rules) and opportunities. RECOPHARMA, represented by project partner Leonardo Picinetti (Europe for Business), focused on Green Public Procurement
Criteria for Waste WaterInfrastructure.
It is widely recognized that public procurement criteria can be an effective instrument in bringing about wider change in the market by creating demand and acceptability for more circular products, and business models, which, at scale, may contribute to reducing the EU’s material consumption. One of RECOPHARMA’s aims is to improve the success of SMEs in public procurements. It is achieving this through contact with EU standardization stakeholders and involving them as future partners in EU Initiatives while at the same time providing credible information, reducing technological risk for purchasers, offering clear indications to relevant stakeholders, public policy-makers or regulators,and ultimately facilitating the entry of SMEs into the market. RECOPHARMA’s participation in the co-creation workshop forged links between SMEs and enabled the necessary flow of information with particular reference to waste water.
Mr Picinetti (Europe for Business)commented:
‘This highly interactive workshop event was a not-to-be-missed opportunity to find out about the latest research into renewable energy innovations, deployment through Green Public Procurement and insight into environmental impact. Stakeholder opinions and knowledge are central to green solutions, and Europe for Business was delighted to present a best practice scenario based on RECOPHARMA’s work.”
Image: Opinion poll held during the XPRESS GPP Co-creation Workshop.
About the RECOPHARMA Project
The RECOPHARMA Project emerged from a need to develop an effective treatment to recover Recalcitrant Cytostatic Drugs (CDs) through the sequential integration of the potential offered by technologies such as Molecularly Imprinted Polymers (MIPs), Reagentless Thermosorption (RTS), Nanocomposites Functional Materials (NFMs) and Advanced Oxidation Processes (AOP).
The RECOPHARMA Project, formed by 8 partners (see partners section), is a Research and Innovation Staff Exchange action, fostering intersectorial mobility between Europe and Cuba.
Initiated on 01/01/2018, during the 48 months of the project, 107 exchanges will be carried out (199 P M). This project is co-financed by the Marie Skłodowska-Curie (MSCA) Research and Innovation Staff Exchange (RISE) of the European Research Framework Horizon2020 (with a budget of 895.000€).Co-funded by the Horizon 2020 Framework Programme of the European Union – Marie Skłodowska-Curie actions